Thy Duong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thy Duong has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Peter J. Meikle
Baker Heart and Diabetes Institute
16 shared publications - Kevin Huynh
Baker Heart and Diabetes Institute
13 shared publications - Corey Giles
Baker Heart and Diabetes Institute
7 shared publications Tingting Wang
Baker Heart and Diabetes Institute
7 shared publications- Gavriel Olshansky
Baker Heart and Diabetes Institute
4 shared publications - Habtamu Bedimo Beyene
Baker Heart and Diabetes Institute
4 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
Human milk short‐chain fatty acid concentrations are not associated with early childhood allergic disease
Background: Short‐chain fatty acids (SCFAs) are microbial metabolites with immunoregulatory properties. Human milk contains SCFAs which have been proposed as potential modulators of infant immune development. We aimed to examine associations between human milk SCFA concentrations and infant allergic disease outcomes in a high‐risk cohort of infants of atopic mothers. Methods: SCFAs were measured by targeted liquid chromatography–mass spectrometry in human milk samples collected at 3 and 6 months postpartum from atopic mothers enrolled in the Infant Fish Oil Supplementation (IFOS) Study ( n = 147). Associations between milk SCFA concentrations and early childhood allergic disease outcomes (atopic dermatitis, food allergy, allergic rhinitis, and allergen sensitisation at 1 and 2–3 years) were examined using logistic regression. Results: Human milk SCFA concentrations were broadly stable between 3 and 6 months postpartum, except for acetate which was significantly elevated at 6 months. No significant associations were observed between human milk SCFA concentrations and any allergic disease outcome after correction for multiple comparisons (all p > .05). Conclusions: Human milk SCFA concentrations are not associated with allergic disease outcomes up to 4 years of age. These findings suggest that oral SCFA exposure via human milk is insufficient to reduce infant allergy risk, and that gut SCFA production may be a more relevant target for future allergy prevention research. image
- 15 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
Open AccessHuman milk short‐chain fatty acid concentrations are not associated with early childhood allergic disease
Background: Short‐chain fatty acids (SCFAs) are microbial metabolites with immunoregulatory properties. Human milk contains SCFAs which have been proposed as potential modulators of infant immune development. We aimed to examine associations between human milk SCFA concentrations and infant allergic disease outcomes in a high‐risk cohort of infants of atopic mothers. Methods: SCFAs were measured by targeted liquid chromatography–mass spectrometry in human milk samples collected at 3 and 6 months postpartum from atopic mothers enrolled in the Infant Fish Oil Supplementation (IFOS) Study ( n = 147). Associations between milk SCFA concentrations and early childhood allergic disease outcomes (atopic dermatitis, food allergy, allergic rhinitis, and allergen sensitisation at 1 and 2–3 years) were examined using logistic regression. Results: Human milk SCFA concentrations were broadly stable between 3 and 6 months postpartum, except for acetate which was significantly elevated at 6 months. No significant associations were observed between human milk SCFA concentrations and any allergic disease outcome after correction for multiple comparisons (all p > .05). Conclusions: Human milk SCFA concentrations are not associated with allergic disease outcomes up to 4 years of age. These findings suggest that oral SCFA exposure via human milk is insufficient to reduce infant allergy risk, and that gut SCFA production may be a more relevant target for future allergy prevention research. image
- Open Access
- 23 September 2026
- Published by Springer Nature in Research Square
Empirically derived dietary patterns, plasma lipidome and their associations with cardiometabolic health and mortality: Findings from prospective cohort studies
Traditional dietary pattern analyses commonly use predefined diet quality, which may not fully capture naturally occurring combinations of foods or their metabolic consequences. We applied an a posteriori approach to identify empirical dietary patterns and examine their lipidomic and health associations in two Australian cohorts: AusDiab (n=10,339) and MCCS (n=2,996). Factor analysis of 36 food groups identified two major patterns: a Western dietary pattern (WD) and a prudent dietary pattern (PD). The PD was associated with lipid species containing docosahexaenoic acid (22:6), whereas the WD was characterised by species enriched in 22:4 and other ω-6 fatty acids; these associations were replicated in MCCS. Ridge regression-derived metabolic signatures explained 35% and 18% of variability in the WD and PD, respectively. Participants in the highest quartile of the PD metabolic signature had a 27% lower risk of mortality (HR 0.73, 95% CI 0.65–0.83), while the FFQ-derived PD was not associated with mortality. Conversely, the highest quartiles of both the WD metabolic signature and FFQ-derived WD were associated with higher mortality risk. These findings demonstrate that empirically derived dietary patterns are reflected in the plasma lipidome and that lipidomic signatures may provide stronger indicators of long-term health risk than dietary assessment alone.
- 23 September 2026
- Published by Springer Nature in Research Square
Open AccessEmpirically derived dietary patterns, plasma lipidome and their associations with cardiometabolic health and mortality: Findings from prospective cohort studies
Traditional dietary pattern analyses commonly use predefined diet quality, which may not fully capture naturally occurring combinations of foods or their metabolic consequences. We applied an a posteriori approach to identify empirical dietary patterns and examine their lipidomic and health associations in two Australian cohorts: AusDiab (n=10,339) and MCCS (n=2,996). Factor analysis of 36 food groups identified two major patterns: a Western dietary pattern (WD) and a prudent dietary pattern (PD). The PD was associated with lipid species containing docosahexaenoic acid (22:6), whereas the WD was characterised by species enriched in 22:4 and other ω-6 fatty acids; these associations were replicated in MCCS. Ridge regression-derived metabolic signatures explained 35% and 18% of variability in the WD and PD, respectively. Participants in the highest quartile of the PD metabolic signature had a 27% lower risk of mortality (HR 0.73, 95% CI 0.65–0.83), while the FFQ-derived PD was not associated with mortality. Conversely, the highest quartiles of both the WD metabolic signature and FFQ-derived WD were associated with higher mortality risk. These findings demonstrate that empirically derived dietary patterns are reflected in the plasma lipidome and that lipidomic signatures may provide stronger indicators of long-term health risk than dietary assessment alone.
- Open Access
Human milk short-chain fatty acid concentrations are not associated with early childhood allergic disease
Background: Short-chain fatty acids (SCFAs) are microbial metabolites with immunoregulatory properties. Human milk contains SCFAs which have been proposed as potential modulators of infant immune development. We aimed to examine associations between human milk SCFA concentrations and infant allergic disease outcomes in a high-risk cohort of infants of atopic mothers. Methods: SCFAs were measured by targeted liquid chromatography-mass spectrometry in human milk samples collected at 3 and 6 months postpartum from atopic mothers enrolled in the Infant Fish Oil Supplementation (IFOS) Study (n=147). Associations between milk SCFA concentrations and early childhood allergic disease outcomes (atopic dermatitis, food allergy, allergic rhinitis, and allergen sensitisation at 1 and 2-3 years) were examined using logistic regression. Results: Human milk SCFA concentrations were broadly stable between 3 and 6 months postpartum, except for acetate which was significantly elevated at 6 months. No significant associations were observed between human milk SCFA concentrations and any allergic disease outcome after correction for multiple comparisons (all p>0.05). Conclusions: Human milk SCFA concentrations are not associated with allergic disease outcomes up to 4 years of age. These findings suggest that oral SCFA exposure via human milk is insufficient to reduce infant allergy risk, and that gut SCFA production may be a more relevant target for future allergy prevention research.
Open AccessHuman milk short-chain fatty acid concentrations are not associated with early childhood allergic disease
Background: Short-chain fatty acids (SCFAs) are microbial metabolites with immunoregulatory properties. Human milk contains SCFAs which have been proposed as potential modulators of infant immune development. We aimed to examine associations between human milk SCFA concentrations and infant allergic disease outcomes in a high-risk cohort of infants of atopic mothers. Methods: SCFAs were measured by targeted liquid chromatography-mass spectrometry in human milk samples collected at 3 and 6 months postpartum from atopic mothers enrolled in the Infant Fish Oil Supplementation (IFOS) Study (n=147). Associations between milk SCFA concentrations and early childhood allergic disease outcomes (atopic dermatitis, food allergy, allergic rhinitis, and allergen sensitisation at 1 and 2-3 years) were examined using logistic regression. Results: Human milk SCFA concentrations were broadly stable between 3 and 6 months postpartum, except for acetate which was significantly elevated at 6 months. No significant associations were observed between human milk SCFA concentrations and any allergic disease outcome after correction for multiple comparisons (all p>0.05). Conclusions: Human milk SCFA concentrations are not associated with allergic disease outcomes up to 4 years of age. These findings suggest that oral SCFA exposure via human milk is insufficient to reduce infant allergy risk, and that gut SCFA production may be a more relevant target for future allergy prevention research.
- Open Access
- 6 April 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1) , 187
Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
- 6 April 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1) , 187
Open AccessAuthor Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
- Open Access
- 30 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Lipidomic analyses of large cohort studies define the role of lipid metabolism in bridging diet and cardio-metabolic health
Diet is a key factor for many diseases, yet the underlying metabolic pathways involved remain poorly understood. We analyze data from 13,335 participants across two large Australian cohorts examining comprehensive lipidomic profiles in relation to diet. We also assess the link between metabolic signatures of dietary quality with cardiometabolic health and all-cause mortality. Here, using linear models and lipid set enrichment analysis, we report characteristic lipidomic profiles associated with dairy [sphingomyelins and lipids esterified with 14:0, 15:0, 17:0 or 17:1 fatty acid], red meat and poultry [alkyl- and alkenyl-phosphatidylcholine and phosphatidylethanolamine notably, with arachidonic acid], and fish intake [higher 22:6, and lower 22:4 fatty acids]. In a Cox proportional hazard regression, metabolic signatures of diet quality showed inverse associations with all–cause mortality with hazard ratios (95% confidence intervals) of 0.89 (0.84–0.93), 0.87 (0.83–0.92), and 0.88 (0.84–0.93) for the Australian Dietary Guideline Index (DGI), the Global Diet Quality Score (DGQS), and the Mediterranean-DASH (Dietary Approaches to Stop Hypertension) Intervention for Neurodegenerative Delay (MIND) score, respectively. Additionally, the intake of nuts (β = −0.07, p = 7.92 × 10⁻¹⁸) and the MIND score (β = −0.07, p = 1.51 × 10⁻¹⁸) were inversely associated with CVD risk. Our data provide new insights into how dietary exposure relates to lipid metabolism and metabolic health, opening avenues for future mechanistic studies and dietary interventions that can inform targeted strategies for the prevention of cardiometabolic diseases.
- 30 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessLipidomic analyses of large cohort studies define the role of lipid metabolism in bridging diet and cardio-metabolic health
Diet is a key factor for many diseases, yet the underlying metabolic pathways involved remain poorly understood. We analyze data from 13,335 participants across two large Australian cohorts examining comprehensive lipidomic profiles in relation to diet. We also assess the link between metabolic signatures of dietary quality with cardiometabolic health and all-cause mortality. Here, using linear models and lipid set enrichment analysis, we report characteristic lipidomic profiles associated with dairy [sphingomyelins and lipids esterified with 14:0, 15:0, 17:0 or 17:1 fatty acid], red meat and poultry [alkyl- and alkenyl-phosphatidylcholine and phosphatidylethanolamine notably, with arachidonic acid], and fish intake [higher 22:6, and lower 22:4 fatty acids]. In a Cox proportional hazard regression, metabolic signatures of diet quality showed inverse associations with all–cause mortality with hazard ratios (95% confidence intervals) of 0.89 (0.84–0.93), 0.87 (0.83–0.92), and 0.88 (0.84–0.93) for the Australian Dietary Guideline Index (DGI), the Global Diet Quality Score (DGQS), and the Mediterranean-DASH (Dietary Approaches to Stop Hypertension) Intervention for Neurodegenerative Delay (MIND) score, respectively. Additionally, the intake of nuts (β = −0.07, p = 7.92 × 10⁻¹⁸) and the MIND score (β = −0.07, p = 1.51 × 10⁻¹⁸) were inversely associated with CVD risk. Our data provide new insights into how dietary exposure relates to lipid metabolism and metabolic health, opening avenues for future mechanistic studies and dietary interventions that can inform targeted strategies for the prevention of cardiometabolic diseases.
- Top Cited PapersOpen Access
- 28 November 2025
- Published by Springer Nature in Nature Cell Biology
- Vol. 27 (12) , 2167-2185
Multi-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma
Extracellular vesicles (EVs) are an essential signalling entity in human plasma implicated in health and disease. Still, their core protein and lipid componentry, which lie at the centre of EV form and function, remain poorly defined. Here we performed high-resolution density gradient fractionation of over 140 human plasma samples to isolate circulating EVs, and systematically constructed their quantitative proteome (4,500 proteins) and lipidome (829 lipids) landscapes using mass spectrometry. We identified a highly conserved panel of 182 proteins (including ADAM10, STEAP23 and STX7) and 52 lipids (including PS, PIPs, Hex2Cer and PAs), providing a deep survey of hallmark molecular features and biological pathways characteristic to circulating EVs. We also mapped the surfaceome diversity, identifying 151 proteins on the EV surface. We further established a set of 42 proteins and 114 lipids features that served as hallmark features of non-EV particles in plasma. We submit ADAM10 and PS(36:1) as conserved EV biological markers that precisely differentiate between EV and non-EV particles. Our findings, which can be explored via an open-source Shiny web tool ( evmap.shinyapps.io/evmap/ ), will serve as a valuable repository to the research community for a clearer understanding of circulating EV biology.
- 28 November 2025
- Published by Springer Nature in Nature Cell Biology
- Vol. 27 (12) , 2167-2185
Top Cited PapersOpen AccessMulti-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma
Extracellular vesicles (EVs) are an essential signalling entity in human plasma implicated in health and disease. Still, their core protein and lipid componentry, which lie at the centre of EV form and function, remain poorly defined. Here we performed high-resolution density gradient fractionation of over 140 human plasma samples to isolate circulating EVs, and systematically constructed their quantitative proteome (4,500 proteins) and lipidome (829 lipids) landscapes using mass spectrometry. We identified a highly conserved panel of 182 proteins (including ADAM10, STEAP23 and STX7) and 52 lipids (including PS, PIPs, Hex2Cer and PAs), providing a deep survey of hallmark molecular features and biological pathways characteristic to circulating EVs. We also mapped the surfaceome diversity, identifying 151 proteins on the EV surface. We further established a set of 42 proteins and 114 lipids features that served as hallmark features of non-EV particles in plasma. We submit ADAM10 and PS(36:1) as conserved EV biological markers that precisely differentiate between EV and non-EV particles. Our findings, which can be explored via an open-source Shiny web tool ( evmap.shinyapps.io/evmap/ ), will serve as a valuable repository to the research community for a clearer understanding of circulating EV biology.
- Open Access
- 8 October 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-19
The protective effect of breastfeeding on infant inflammation: a mediation analysis of the plasma lipidome and metabolome
Background: Inflammation has long-term health impacts across the life course. Breastfeeding substantially reduces inflammation risk, but key pathways, including the extent that this is due to protection against early life infection, are poorly understood. We aimed to investigate the relationships between breastfeeding, inflammation, and infection burden, and to determine the extent to which metabolomic and lipidomic profiles associated with breastfeeding mediate these health outcomes. Methods: We utilised data from the Barwon Infant Study (BIS), a longitudinal birth cohort in Victoria, Australia. Infants (n = 889) with available breastfeeding (categorised as yes/no) clinical, metabolomic, and Lipidomic data at 6 and/or 12 months were included (n = 793 at 6 months, n = 734 at 12 months). Inflammation, measured via glycoprotein acetyls (GlycA), at 6 and 12 months and infection burden, including parent-reported and medically attended infections assessed through standardised 3-monthly questionnaires were used as outcomes. Results: Any breastfeeding, regardless of supplementary feeding, was associated with lower inflammation, fewer infections, and significant, potentially beneficial changes in metabolomic and lipidomic markers, particularly plasmalogens. There was evidence of bidirectional mediation: metabolomic biomarkers and lipids mediated breastfeeding’s effects on inflammation, while inflammation partly mediated breastfeeding’s impact on certain metabolites and lipids. Conclusions: These findings highlight pathways through which breastfeeding reduces inflammation and infection burden, identifying potential targets for optimising infant feeding.
- 8 October 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-19
Open AccessThe protective effect of breastfeeding on infant inflammation: a mediation analysis of the plasma lipidome and metabolome
Background: Inflammation has long-term health impacts across the life course. Breastfeeding substantially reduces inflammation risk, but key pathways, including the extent that this is due to protection against early life infection, are poorly understood. We aimed to investigate the relationships between breastfeeding, inflammation, and infection burden, and to determine the extent to which metabolomic and lipidomic profiles associated with breastfeeding mediate these health outcomes. Methods: We utilised data from the Barwon Infant Study (BIS), a longitudinal birth cohort in Victoria, Australia. Infants (n = 889) with available breastfeeding (categorised as yes/no) clinical, metabolomic, and Lipidomic data at 6 and/or 12 months were included (n = 793 at 6 months, n = 734 at 12 months). Inflammation, measured via glycoprotein acetyls (GlycA), at 6 and 12 months and infection burden, including parent-reported and medically attended infections assessed through standardised 3-monthly questionnaires were used as outcomes. Results: Any breastfeeding, regardless of supplementary feeding, was associated with lower inflammation, fewer infections, and significant, potentially beneficial changes in metabolomic and lipidomic markers, particularly plasmalogens. There was evidence of bidirectional mediation: metabolomic biomarkers and lipids mediated breastfeeding’s effects on inflammation, while inflammation partly mediated breastfeeding’s impact on certain metabolites and lipids. Conclusions: These findings highlight pathways through which breastfeeding reduces inflammation and infection burden, identifying potential targets for optimising infant feeding.
- Open Access
- 17 April 2025
- Published by Springer Nature in Research Square
Lipidomic analyses of large cohort studies define the role of lipid metabolism in bridging diet and metabolic health
Diet is a key factor for many diseases, yet the underlying metabolic pathways involved remain poorly understood. We analyzed data from 13,335 participants across two large Australian cohorts examining comprehensive lipidomic profiles in relation to diet. We also assessed the link between metabolic signatures of dietary quality with cardiometabolic health and all-cause mortality. Here, we report characteristic lipidomic profiles linked to dairy [sphingomyelins and lipids esterified with 14:0, 15:0, 17:0 or 17:1 fatty acid], red meat and poultry [alkyl- and alkenyl-phosphatidylcholine and phosphatidylethanolamine notably, with arachidonic acid], and fish intake [higher 22:6, and lower 22:4 fatty acids]. The metabolic signatures of diet quality showed inverse associations with all–cause mortality with hazard ratios (95% confidence intervals) of 0.89 (0.84–0.93), 0.87 (0.83–0.92), and 0.88 (0.84–0.93) for the Australian Dietary Guideline Index (DGI), the Global Diet Quality Score (DGQS), and the Mediterranean-DASH (Dietary Approaches to Stop Hypertension) Intervention for Neurodegenerative Delay (MIND) score, respectively. Additionally, the intake of nuts (β = -0.07, p = 7.92 × 10⁻¹⁸) and the MIND score (β = -0.07, p = 1.51 × 10⁻¹⁸) were inversely associated with CVD risk. Our data highlight the critical role of diet in influencing lipid metabolism, thereby impacting metabolic health and mortality risk and provide a framework for the development of a precision health approach to dietary intervention.
- 17 April 2025
- Published by Springer Nature in Research Square
Open AccessLipidomic analyses of large cohort studies define the role of lipid metabolism in bridging diet and metabolic health
Diet is a key factor for many diseases, yet the underlying metabolic pathways involved remain poorly understood. We analyzed data from 13,335 participants across two large Australian cohorts examining comprehensive lipidomic profiles in relation to diet. We also assessed the link between metabolic signatures of dietary quality with cardiometabolic health and all-cause mortality. Here, we report characteristic lipidomic profiles linked to dairy [sphingomyelins and lipids esterified with 14:0, 15:0, 17:0 or 17:1 fatty acid], red meat and poultry [alkyl- and alkenyl-phosphatidylcholine and phosphatidylethanolamine notably, with arachidonic acid], and fish intake [higher 22:6, and lower 22:4 fatty acids]. The metabolic signatures of diet quality showed inverse associations with all–cause mortality with hazard ratios (95% confidence intervals) of 0.89 (0.84–0.93), 0.87 (0.83–0.92), and 0.88 (0.84–0.93) for the Australian Dietary Guideline Index (DGI), the Global Diet Quality Score (DGQS), and the Mediterranean-DASH (Dietary Approaches to Stop Hypertension) Intervention for Neurodegenerative Delay (MIND) score, respectively. Additionally, the intake of nuts (β = -0.07, p = 7.92 × 10⁻¹⁸) and the MIND score (β = -0.07, p = 1.51 × 10⁻¹⁸) were inversely associated with CVD risk. Our data highlight the critical role of diet in influencing lipid metabolism, thereby impacting metabolic health and mortality risk and provide a framework for the development of a precision health approach to dietary intervention.
- Open Access
- 8 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-21
Mitochondrial damage in muscle specific PolG mutant mice activates the integrated stress response and disrupts the mitochondrial folate cycle
During mitochondrial damage, information is relayed between the mitochondria and nucleus to coordinate precise responses to preserve cellular health. One such pathway is the mitochondrial integrated stress response (mtISR), which is known to be activated by mitochondrial DNA (mtDNA) damage. However, the causal molecular signals responsible for activation of the mtISR remain mostly unknown. A gene often associated with mtDNA mutations/deletions is Polg1, which encodes the mitochondrial DNA Polymerase γ (PolG). Here, we describe an inducible, tissue specific model of PolG mutation, which in muscle specific animals leads to rapid development of mitochondrial dysfunction and muscular degeneration in male animals from ~5 months of age. Detailed molecular profiling demonstrated robust activation of the mtISR in muscles from these animals. This was accompanied by striking alterations to enzymes in the mitochondrial folate cycle that was likely driven by a specific depletion in the folate cycle metabolite 5,10 methenyl-THF, strongly implying imbalanced folate intermediates as a previously unrecognised pathology linking the mtISR and mitochondrial disease.
- 8 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-21
Open AccessMitochondrial damage in muscle specific PolG mutant mice activates the integrated stress response and disrupts the mitochondrial folate cycle
During mitochondrial damage, information is relayed between the mitochondria and nucleus to coordinate precise responses to preserve cellular health. One such pathway is the mitochondrial integrated stress response (mtISR), which is known to be activated by mitochondrial DNA (mtDNA) damage. However, the causal molecular signals responsible for activation of the mtISR remain mostly unknown. A gene often associated with mtDNA mutations/deletions is Polg1, which encodes the mitochondrial DNA Polymerase γ (PolG). Here, we describe an inducible, tissue specific model of PolG mutation, which in muscle specific animals leads to rapid development of mitochondrial dysfunction and muscular degeneration in male animals from ~5 months of age. Detailed molecular profiling demonstrated robust activation of the mtISR in muscles from these animals. This was accompanied by striking alterations to enzymes in the mitochondrial folate cycle that was likely driven by a specific depletion in the folate cycle metabolite 5,10 methenyl-THF, strongly implying imbalanced folate intermediates as a previously unrecognised pathology linking the mtISR and mitochondrial disease.
- Open Access
- 9 January 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-15
Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
Background Alzheimer’s disease (AD) is a major neurodegenerative disorder with significant environmental factors, including diet and lifestyle, influencing its onset and progression. Although previous studies have suggested that certain diets may reduce the incidence of AD, the underlying mechanisms remain unclear. Method In this post-hoc analysis of a randomized crossover study of 20 elderly adults, we investigated the effects of a modified Mediterranean ketogenic diet (MMKD) on the plasma lipidome in the context of AD biomarkers, analyzing 784 lipid species across 47 classes using a targeted lipidomics platform. Results Here we identified substantial changes in response to MMKD intervention, aside from metabolic changes associated with a ketogenic diet, we identified a a global elevation across all plasmanyl and plasmenyl ether lipid species, with many changes linked to clinical and biochemical markers of AD. We further validated our findings by leveraging our prior clinical studies into lipid related changeswith AD (n = 1912), and found that the lipidomic signature with MMKD was inversely associated with the lipidomic signature of prevalent and incident AD. Conclusions Intervention with a MMKD was able to alter the plasma lipidome in ways that contrast with AD-associated patterns. Given its low risk and cost, MMKD could be a promising approach for prevention or early symptomatic treatment of AD.
- 9 January 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-15
Open AccessConsuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
Background Alzheimer’s disease (AD) is a major neurodegenerative disorder with significant environmental factors, including diet and lifestyle, influencing its onset and progression. Although previous studies have suggested that certain diets may reduce the incidence of AD, the underlying mechanisms remain unclear. Method In this post-hoc analysis of a randomized crossover study of 20 elderly adults, we investigated the effects of a modified Mediterranean ketogenic diet (MMKD) on the plasma lipidome in the context of AD biomarkers, analyzing 784 lipid species across 47 classes using a targeted lipidomics platform. Results Here we identified substantial changes in response to MMKD intervention, aside from metabolic changes associated with a ketogenic diet, we identified a a global elevation across all plasmanyl and plasmenyl ether lipid species, with many changes linked to clinical and biochemical markers of AD. We further validated our findings by leveraging our prior clinical studies into lipid related changeswith AD (n = 1912), and found that the lipidomic signature with MMKD was inversely associated with the lipidomic signature of prevalent and incident AD. Conclusions Intervention with a MMKD was able to alter the plasma lipidome in ways that contrast with AD-associated patterns. Given its low risk and cost, MMKD could be a promising approach for prevention or early symptomatic treatment of AD.